EpiBone
A revolutionary bone reconstruction company that grows living bone tissue from patients' own cells.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD114—172m (Dealroom.co estimates Dec 2022.)
New York City New York (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Seed | |
N/A | Early VC | ||
$560k | Convertible | ||
N/A | N/A | Grant | |
$1m | Grant | ||
N/A | Seed | ||
N/A | N/A | Early VC | |
* | N/A | $750k | Debt |
* | $1.0m | Seed | |
* | N/A | $18.5m | Late VC |
Total Funding | AUD32.8m |
Related Content
Recent News about EpiBone
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.